Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Virology
|
November 1, 1993
Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency
J E Strong, D Tang, P W Lee
Biochemical and Biophysical Research Communications
|
May 14, 1979
Interaction of covalently closed circular PM-2 DNA and hedamycin
S Mong, J E Strong, S T Crooke
Cancer Research
|
October 1, 1979
Use of PM-2 DNA degradation as a pharmacokinetic assay for bleomycin
L Galvan, J E Strong, S T Crooke
Cancer Treatment Reports
|
November 1, 1977
Specificity of antisera produced against bleomycin
J E Strong, A Broughton, S T Crooke
American Heart Journal
|
April 1, 1978
Bacterial endocarditis: an analysis of factors affecting long-term survival
K M McNeill, J E Strong, W R Lockwood
Psychological Reports
|
October 17, 1998
Validity of the Perceived Criticism Measure in an undergraduate sample
J D White, J E Strong, D L Chambless
Molecular Pharmacology
|
January 1, 1980
Interaction of anthracyclines with covalently closed circular DNA
S Mong, V H DuVernay, J E Strong, et al.
Bulletin De La Societe De Pathologie Exotique (1990)
|
November 5, 2005
Laboratory diagnosis of Ebola and Marburg hemorrhagic fever
A Grolla, A Lucht, D Dick, et al.
Cancer
|
December 1, 1977
Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay
A Broughton, J E Strong, P Y Holoye, et al.
Anaesthesia
|
November 1, 1979
Phenylbutazone self-poisoning treated by charcoal haemoperfusion
J E Strong, J Wilson, J F Douglas, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Virology
|
November 1, 1993
Evidence that the epidermal growth factor receptor on host cells confers reovirus infection efficiency
J E Strong, D Tang, P W Lee
Biochemical and Biophysical Research Communications
|
May 14, 1979
Interaction of covalently closed circular PM-2 DNA and hedamycin
S Mong, J E Strong, S T Crooke
Cancer Research
|
October 1, 1979
Use of PM-2 DNA degradation as a pharmacokinetic assay for bleomycin
L Galvan, J E Strong, S T Crooke
Cancer Treatment Reports
|
November 1, 1977
Specificity of antisera produced against bleomycin
J E Strong, A Broughton, S T Crooke
American Heart Journal
|
April 1, 1978
Bacterial endocarditis: an analysis of factors affecting long-term survival
K M McNeill, J E Strong, W R Lockwood
Psychological Reports
|
October 17, 1998
Validity of the Perceived Criticism Measure in an undergraduate sample
J D White, J E Strong, D L Chambless
Molecular Pharmacology
|
January 1, 1980
Interaction of anthracyclines with covalently closed circular DNA
S Mong, V H DuVernay, J E Strong, et al.
Bulletin De La Societe De Pathologie Exotique (1990)
|
November 5, 2005
Laboratory diagnosis of Ebola and Marburg hemorrhagic fever
A Grolla, A Lucht, D Dick, et al.
Cancer
|
December 1, 1977
Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay
A Broughton, J E Strong, P Y Holoye, et al.
Anaesthesia
|
November 1, 1979
Phenylbutazone self-poisoning treated by charcoal haemoperfusion
J E Strong, J Wilson, J F Douglas, et al.
Page
of 4